Cytyc Looking To Expand Ductal Lavage Franchise With Help Of HRT Study

Cytyc plans to leverage results from a high-profile hormone replacement therapy study of postmenopausal women at risk for breast cancer in marketing its FirstCyte ductal lavage technology to ob/gyns

More from Archive

More from Medtech Insight